- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
NextBioMedical Co Ltd (389650)
NextBioMedical Co Ltd stock price live, this page displays KQ 389650 stock exchange data. View the 389650 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the NextBioMedical Co Ltd real time stock price chart below.
What Is the NextBioMedical Co Ltd Stock Price Today?
The NextBioMedical Co Ltd stock price today is 85,400.00.
What Is the Stock Symbol for NextBioMedical Co Ltd?
The stock symbol for NextBioMedical Co Ltd is ""389650.""
What Stock Exchange Does NextBioMedical Co Ltd Trade On?
NextBioMedical Co Ltd is listed and trades on the KOSDAQ stock exchange.
Is NextBioMedical Co Ltd a Good Stock to Buy?
Determining whether NextBioMedical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 389650 quote. (ISIN: KR7389650003)
What Is the NextBioMedical Co Ltd Stock Price Today?
The NextBioMedical Co Ltd stock price today is 85,400.00.
What Is the Stock Symbol for NextBioMedical Co Ltd?
The stock symbol for NextBioMedical Co Ltd is ""389650.""
What Stock Exchange Does NextBioMedical Co Ltd Trade On?
NextBioMedical Co Ltd is listed and trades on the KOSDAQ stock exchange.
Is NextBioMedical Co Ltd a Good Stock to Buy?
Determining whether NextBioMedical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 389650 quote. (ISIN: KR7389650003)
KOSDAQ
Currency in KRW
85,400.00
+2,600.00(+3.14%)
Closed·
Fair Value
An estimate of a NextBioMedical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
78,600.00
86,100.00
52 wk Range
35,500.00
89,600.00
Unusual trading volume
1/2
Fair Value
An estimate of a NextBioMedical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
78,600.0086,100.00
52 wk Range
35,500.0089,600.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
389650 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a NextBioMedical's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
100,000.00
Upside
+17.10%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
NextBioMedical Co Ltd Company Profile
Next Biomedical Co.,Ltd. engages in the research and development, production, and development of therapeutics, drug delivery system and drug-medical device products in South Korea. It offers hemostatic material for endoscope; and microspheres for vascular embolization. The company was founded in 2014 and is based in Incheon, South Korea.
Compare 389650 to Peers and Sector
Metrics to compare | 389650 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship389650PeersSector | |
|---|---|---|---|---|
P/E Ratio | −5,948.5x | −3.7x | −0.6x | |
PEG Ratio | 2.12 | −0.02 | 0.00 | |
Price/Book | 15.1x | 2.0x | 2.6x | |
Price / LTM Sales | 47.0x | 2.6x | 3.3x | |
Upside (Analyst Target) | 17.1% | 67.8% | 39.0% | |
Fair Value Upside | Unlock | −0.9% | 3.9% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 100,000.00
(+17.10% Upside)
Earnings
Latest Release
Nov 14, 2025
EPS / Forecast
131.00 / --
Revenue / Forecast
4.90B / 5.05B
People Also Watch
FAQ
What Stock Exchange Does NextBioMedical Trade On?
NextBioMedical is listed and trades on the KOSDAQ stock exchange.
What Is the Stock Symbol for NextBioMedical?
The stock symbol for NextBioMedical is "389650."
What Is the NextBioMedical Market Cap?
As of today, NextBioMedical market cap is 700.61B.
What Is NextBioMedical's Earnings Per Share (TTM)?
The NextBioMedical EPS (TTM) is -603.13.
When Is the Next NextBioMedical Earnings Date?
NextBioMedical will release its next earnings report on 11 Mar 2026.
From a Technical Analysis Perspective, Is 389650 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has NextBioMedical Stock Split?
NextBioMedical has split 0 times.
What is the current trading status of NextBioMedical (389650)?
As of 30 Nov 2025, NextBioMedical (389650) is trading at a price of 85,400.00, with a previous close of 82,800.00. The stock has fluctuated within a day range of 78,600.00 to 86,100.00, while its 52-week range spans from 35,500.00 to 89,600.00.
What Is NextBioMedical (389650) Price Target According to Analysts?
The average 12-month price target for NextBioMedical is KRW100000, with a high estimate of KRW120000 and a low estimate of KRW80000. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +17.10% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.